|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||63.68 / 99.14|
The healthcare firm has agreed to sell its active pharmaceutical ingredients business and its Russia consumer healthcare international unit.
Stocks fall for their third day in a row.
Teva's not the only one struggling to stay afloat in Israel.
The prices of generic drugs are declining as more of them are becoming available on the market along with pressure from major retail pharmacies.
The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.
The top executives at these seven companies all left after pressure from activist investors in 2017.
Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..
Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.